Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer
Ee Ming Wong, Melissa C Southey, Stephen B Fox, Melissa A Brown, James G Dowty, Mark A Jenkins, Graham G Giles, John L Hopper, Alexander Dobrovic
Cancer prevention research | AMER ASSOC CANCER RESEARCH | Published : 2011
Awarded by U.S. Department of Defense
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by United States National Institutes of Health (NIH)
Awarded by United States National Cancer Institute, National Institutes of Health
This study was supported by grants to A. Dobrovic from the U.S. Department of Defense Breast Cancer Research Program under award number W81XWH-06-1-0670, the Cancer Council of Victoria, Susan Komen for the Cure, and the National Breast Cancer Foundation of Australia, and by a grant to M.C. Southey from the Cancer Council of Victoria. The ABCFR was supported by the National Health and Medical Research Council of Australia (NHMRC) , the United States National Institutes of Health (NIH) [CA102740-01A2], and by the United States National Cancer Institute, National Institutes of Health [CA-06-503] through cooperative agreements with members of the BCFR and principal investigators Cancer Care Ontario [CA69467], Columbia University [CA69398], Fox Chase Cancer Center [CA69631], Huntsman Cancer Institute [CA69446], Northern California Cancer Center [CA69417], University of Melbourne [CA69638]. The ABCFR was initially supported by the NHMRC, the New South Wales Cancer Council and the Victorian Health Promotion Foundation. The ABCFR has also received support from the Victorian Breast Cancer Research Consortium of which M. C. Southey and J. L. Hopper are group leaders. J. L. Hopper is an Australia Fellow of the NHMRC. M. C. Southey is a Senior Research Fellow of the NHMRC. E. M. Wong was supported by the Dora Lush postgraduate biomedical scholarship from the NHMRC.